Document:

EXHIBIT
10.1

 

CONVERTIBLE
PROMISSORY NOTE

 

	$__________
	 	Cambridge, Massachusetts
	 	 	Date: ___________

 

For
value received, the undersigned, Pathfinder Cell Therapy, Inc., a Delaware corporation (the “ Borrower ”), hereby
unconditionally promises to pay to the order of _____________ (the “ Payee ”), the principal sum of   $_______
  and   00/100   Dollars   ($_________ ), together with interest to
maturity (whether by lapse of time, acceleration or otherwise) on the balance of principal remaining from time to time outstanding
at a rate per annum equal to 6%. Interest shall be calculated on the basis of a 360-day year and actual days.

 

The
outstanding principal amount, together with accrued interest, of this Promissory Note shall become due and payable on the first
anniversary of the date hereof.

 

Payee
may elect, at any time prior to completion or termination of the Capital Raise (defined below), upon written notice to Borrower,
to convert all or a portion of the outstanding principal and/or interest hereof, to shares of common stock of the Borrower, for
the subscription price thereof, in the Capital Raise.  “Capital Raise” has the meaning used in that certain
agreement and plan of merger dated December 22, 2010 (as amended) by and among Borrower, a wholly-owned subsidiary of Borrower,
and Pathfinder, LLC, a Massachusetts limited liability company, pursuant to which Borrower acquired Pathfinder, LLC in a merger
transaction, the initial closing of which Capital Raise occurred in September 2011 immediately after the merger. As a condition
to any such conversion, Payee shall execute and deliver to Borrower such agreements and documentation as Borrower requires of
other investors in the Capital Raise.

 

The
Borrower shall have the right to prepay, at any time, all or any portion of the principal indebtedness evidenced by this Note,
together with any accrued interest.

 

No
failure by the holder of this Note to exercise, and no delay in exercising, any right or power hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise by such holder of any right or power preclude any other or further exercise
thereof or the exercise of any other right or power.  The rights and remedies of the holder hereof as herein specified
are cumulative and not exclusive of any other rights or remedies which such holder may otherwise have.

 

The
undersigned agrees to pay all costs and expenses incurred by the holder hereof in enforcing this Note, including, without limitation,
reasonable attorneys’ fees and disbursements.

 

     

     

    

 

Every
maker, endorser and guarantor of this Note hereby waives presentment, demand and protest, and consents to any and all extensions
and other indulgences granted by the holder hereof and agrees that no such extensions or other indulgences granted by the holder,
and no discharge or release of any other party primarily or secondarily liable on this Note, or of any collateral securing this
Note, shall operate to discharge the indebtedness evidenced by this Note.  If this Note is signed by more than one person,
all references to the Borrower shall apply to each of them and their liabilities hereunder shall be joint and several.

 

Any
notice of non-payment shall be deemed given when delivered in hand or when mailed, postage prepaid, by certified or registered
mail, return receipt requested to the Borrower at 12 Bow Street, Cambridge, Massachusetts 02138 or sent thereto by Federal Express
or comparable overnight courier.

 

This
Note shall be governed and construed in accordance with the laws of the State of New York applicable to contracts made and to
be performed therein (excluding choice of law principles).

 

IN
WITNESS WHEREOF, the undersigned has executed or caused this Note to be executed under seal as of the year and day first written
above.

 

	WITNESS 	 	PATHFINDER
    CELL THERAPY, INC.
	 	 	 	 
	 	 	By:	 
	 	 	 	Richard
    L. Franklin, CEO

 

    	 	2	 

     

    

 

	Schedule of Promissory Notes
	 	 	 	 	 	 
	Date of issuance	 	Note Holder	 	Principal amount	 
	 	 	 	 	 	 
	February 2, 2012	 	Falcon Corporate Investments Limited	 	$	150,000	 
	 	 	 	 	 	 	 
	February 29, 2012	 	Falcon Corporate Investments Limited	 	$	170,000	 
	 	 	 	 	 	 	 
	March 15, 2012	 	Falcon Corporate Investments Limited	 	$	250,000	 
	 	 	 	 	 	 	 
	April 23, 2012	 	Falcon Corporate Investments Limited	 	$	150,000	 
	 	 	 	 	 	 	 
	May 25, 2012	 	Skye Asset Management SA	 	$	270,000	 
	 	 	 	 	 	 	 
	June 20, 2012	 	Ventura, Inc.	 	$	225,000	 
	 	 	 	 	 	 	 
	July 27, 2012	 	Ventura, Inc.	 	$	50,000	 
	 	 	 	 	 	 	 
	August 17, 2012	 	Breisgau Bio Ventures SA	 	$	100,000	 
	 	 	 	 	 	 	 
	October 1, 2012	 	Breisgau Bio Ventures SA	 	$	200,000	 
	 	 	 	 	 	 	 
	October 23, 2012	 	Breisgau Bio Ventures SA	 	$	200,000	 
	 	 	 	 	 	 	 
	November 20, 2012	 	Breisgau Bio Ventures SA	 	$	70,000	 
	 	 	 	 	 	 	 
	December 4, 2012	 	Breisgau Bio Ventures SA	 	$	70,000	 
	 	 	 	 	 	 	 
	December 21, 2012	 	Breisgau Bio Ventures SA	 	$	60,000	 
	 	 	 	 	 	 	 
	January 9, 2013	 	Breisgau Bio Ventures SA	 	$	75,000	 
	 	 	 	 	 	 	 
	January 28, 2013	 	Breisgau Bio Ventures SA	 	$	130,000	 
	 	 	 	 	 	 	 
	March 4, 2013	 	Mr. Joerg Gruber	 	$	100,000	 
	 	 	 	 	 	 	 
	April 2, 2013	 	Ventura, Inc.	 	$	150,000	 
	 	 	 	 	 	 	 
	April 29, 2013	 	Ventura, Inc.	 	$	150,000	 
	 	 	 	 	 	 	 
	 May 28, 2013	 	Breisgau Bio Ventures SA	 	$	250,000	 
	 	 	 	 	 	 	 
	June 26, 2013	 	Breisgau Bio Ventures SA	 	$	150,000	 
	 	 	 	 	 	 	 
	July 24, 2013	 	Breisgau Bio Ventures SA	 	$	170,000	 

 

    	 	3	 

     

    

 

	Date of issuance	 	Note Holder	 	Principal amount	 
		 	 	 	 	 	 
	August 24, 2013	 	Breisgau Bio Ventures SA	 	$	100,000	 
	 	 	 	 	 	 	 
	September 26, 2013	 	Breisgau Bio Ventures SA	 	$	100,000	 
	 	 	 	 	 	 	 
	October 22, 2013	 	Breisgau Bio Ventures SA	 	$	135,000	 
	 	 	 	 	 	 	 
	November 22, 2013	 	Breisgau Bio Ventures SA	 	$	100,000	 
	 	 	 	 	 	 	 
	December 20, 2013	 	Breisgau Bio Ventures SA	 	$	125,000	 
	 	 	 	 	 	 	 
	January 21, 2014	 	Breisgau Bio Ventures SA	 	$	105,000	 
	 	 	 	 	 	 	 
	February 24, 2014	 	Breisgau Bio Ventures SA	 	$	120,000	 
	 	 	 	 	 	 	 
	March 25, 2014	 	Breisgau Bio Ventures SA	 	$	105,000	 
	 	 	 	 	 	 	 
	April 24, 2014	 	Ventura, Inc.	 	$	100,000	 
	 	 	 	 	 	 	 
	May 28, 2014	 	Ventura, Inc.	 	$	120,000	 
	 	 	 	 	 	 	 
	June 5, 2014	 	Ventura, Inc.	 	$	30,000	 
	 	 	 	 	 	 	 
	June 26, 2014	 	Ventura, Inc.	 	$	50,000	 
	 	 	 	 	 	 	 
	August 5, 2014	 	Ventura, Inc.	 	$	50,000	 
	 	 	 	 	 	 	 
	August 21, 2014	 	Ventura, Inc.	 	$	100,000	 
	 	 	 	 	 	 	 
	September 25, 2014	 	Ventura, Inc.	 	$	80,000	 
	 	 	 	 	 	 	 
	October 24, 2014	 	Ventura, Inc.	 	$	35,000	 
	 	 	 	 	 	 	 
	November 28, 2014	 	Ventura, Inc.	 	$	60,000	 
	 	 	 	 	 	 	 
	December 30, 2014	 	Ventura, Inc.	 	$	50,000	 
	 	 	 	 	 	 	 
	February 2, 2015	 	Ventura, Inc.	 	$	75,000	 
	 	 	 	 	 	 	 
	March 5, 2015	 	Ventura, Inc.	 	$	55,000	 
	 	 	 	 	 	 	 
	March 27, 2015	 	Breisgau Bio Ventures SA	 	$	55,000	 
	 	 	 	 	 	 	 
	May 11, 2015	 	Breisgau Bio Ventures SA	 	$	50,000	 
	 	 	 	 	 	 	 
	June 5, 2015	 	Breisgau Bio Ventures SA	 	$	42,000	 
	 	 	 	 	 	 	 
	July 16, 2015	 	Breisgau Bio Ventures SA	 	$	75,000	 
	August 17, 2015	 	Breisgau Bio Ventures SA	 	$	59,000	 
	August 28, 2015	 	Breisgau Bio Ventures SA	 	$	53,000	 
	October 3, 2015	 	Breisgau Bio Ventures SA	 	$	50,000	 
	November 3, 2015	 	Breisgau Bio Ventures SA	 	$	48,000	 
	 	 	 	 	 	 	 
	 	 	Aggregate Principal amount	 	$	5,267,000	 

 

 

4ex10-88.htm

Exhibit 10.88

 

 

 

PLEDGOR FEE AND REIMBURSEMENT AGREEMENT

 

THIS PLEDGOR FEE AND REIMBURSEMENT AGREEMENT (this “Agreement”) is entered into as of this 13th day of August, 2015 between OmniComm Systems, Inc., a Delaware corporation (“OmniComm”), and Cornelis F. Wit, not individually but as trustee under the provisions of a trust agreement dated April 24, 2012, as amended and known as the Cornelis F. Wit Revocable Trust (“Wit”, and his respective executors, heirs, personal and legal representatives, successors, and assigns, collectively referred to herein as “Pledgor”).

 

WHEREAS, on March 18, 2013, OmniComm entered into a $2,000,000 Promissory Note (“Promissory Note”) for a revolving line of credit with The Northern Trust Company (“Northern Trust”), which Promissory Note was renewed and increased to $4,000,000 on December 18, 2013 and further renewed and increased to $5,000,000 on February 3, 2015 (collectively, the “Line of Credit”); the Line of Credit matures on February 2, 2018 (“Maturity Date”) and carries a variable interest rate based on the prime rate (published in the “Money Rates” table in the Easter Edition of The Wall Street Journal as the prime rate), but in no event less than 2.750% (“Interest”);

 

WHEREAS, in order to induce Northern Trust to execute the Line of Credit, on March 18, 2013 the Pledgor, not individually but as trustee under the provisions of a trust agreement dated April 24, 2012, as amended and known as the Cornelis F. Wit Revocable Trust (“Trust”) executed and delivered that certain Pledge Agreement and Securities Account Control Agreement, to provide certain collateral, in each case (the “Collateral”), in favor of Northern Trust, to secure the payment obligations of OmniComm pursuant to the Line of Credit, which pledge of Collateral was renewed under a Pledge Agreement and Securities Account Control Agreement dated December 18, 2013, and further renewed under a Pledge Agreement and Securities Account Control Agreement dated February 3, 2015 (collectively the “Pledge Agreement(s)” and “Securities Account Control Agreement(s)”);

 

WHEREAS, as a material inducement for the Pledgor, who is the Chief Executive Officer and a director of OmniComm, to execute the Pledge Agreements, the Securities Account Control Agreements and provide the Collateral, OmniComm has agreed to pay to the Pledgor a fee and reimburse and indemnify the Pledgor, all as more fully set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the mutual: promises and covenants contained herein and for other good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

1. Pledgor Fee. In consideration of the execution by the Pledgor of the Pledge Agreements, the Securities Account Control Agreements and provide the Collateral, effective and commencing on March 18, 2013 OmniComm shall pay to the Pledgor 2.0% interest on the required amount of Collateral pledged pursuant to the terms of the Pledge Agreement (the “Pledge Fee”), payable monthly and shall continue to pay for so long as Pledgor shall be subject to any possible claim relating to a Reimbursable Event.

 

2. Reimbursement. In the event any of the Collateral pursuant to the Pledge Agreement is foreclosed (referred to herein as a “Reimbursable Event”), OmniComm shall reimburse Pledgor for the value of the Collateral foreclosed as provided in Section 3 herein.

 

3. New Promissory Note. In the event (i) OmniComm does not pay the Pledge Fee to Pledgor pursuant to Section 1 herein, or (ii) a Reimbursable Event occurs, Pledgor and OmniComm agree that OmniComm shall immediately issue a promissory note in favor of Pledgor in the principal amount equal to the value of the Collateral foreclosed and/or the unpaid Pledge Fee, which promissory note shall bear Interest at the then current promissory note rate, and have the same Maturity Date, as provided in the Line of Credit.

 

 

 

 

Exhibit 10.88

 

 

4. Indemnification. OmniComm shall indemnify and hold the Pledgor harmless, to the fullest extent permitted by the law, from and against any and all liability, claims, losses, damages, costs and expenses, including, without limitation, counsel fees and disbursements, incurred by the Pledgor as a direct or indirect result of the transactions contemplated hereby, as soon as practicable but in any event no later than ten days after written demand is presented to OmniComm by the Pledgor. Such indemnification shall include any and all awards, judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges, including the claimant’s costs, counsel fees and disbursements, paid or payable in connection with or in respect of such awards, judgments, fines, penalties or amounts paid in settlement) of any such claim.

 

5. Payments. All payments hereunder to Pledgor shall be made (i) without set-off, deduction or counterclaim of any kind whatsoever, and (ii) free and clear of and without deduction for or on account of any present or future taxes or duties of any nature now or hereafter imposed, unless otherwise required by law.

 

6. Pledgors’ Remedies. (a) If Pledgor has not been reimbursed or indemnified, Pledgor shall, in addition to any other remedies it may have, be entitled to bring suit against OmniComm. Any action or proceeding arising out of or relating to this Agreement shall be brought in Broward County in the State of Florida and each party agrees to such jurisdiction and venue.

 

(b) Reimbursement by OmniComm. To the extent Pledgor is successful in such action, OmniComm shall, in addition to any other sums that may be due, pay any and all expenses which are incurred by the Pledgor in connection with such suit against OmniComm, including, but not limited to, the Pledgor’s counsel fees and disbursements.

 

(c) Non-Exclusive Rights. The reimbursement and indemnification provided by this Agreement shall not be deemed exclusive of any rights to which Pledgor may be entitled under laws in effect now or in the future, or otherwise.

 

7. Future Pledges; Continuation of Agreement. The parties agree that, in the event Pledgor executes a future pledge agreement(s) and securities account control agreement(s), or pledges any additional collateral, then in each case this Agreement shall apply and govern the terms of reimbursement and indemnification between the parties, and all obligations of OmniComm contained herein shall continue for so long as Pledgor shall be subject to any possible claim relating to a Reimbursable Event.

 

8. General.

 

(a) Assignment. This Assignment shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective executors, heirs, personal and legal representatives, successors and assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of OmniComm.

 

(b) No Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

 

(c) Severability. The provisions of this Agreement shall be severable in the event that any of the provisions hereof (including any provision within a single section, paragraph or sentence) are held by a court of competent jurisdiction to be invalid, void or otherwise unenforceable, and the remaining provisions shall remain enforceable to the fullest extent permitted by law.

 

 

 

 

Exhibit 10.88

 

 

(d) Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Florida applicable to contracts made and to be performed in such state, but excluding any conflicts-of-law rule or principle which might refer such governance, construction or enforcement to the laws of another state or country.

 

(e) Notices. Any notices or other communications required or permitted under, or otherwise in connection with, this Agreement shall be in writing and shall be deemed to have been duly given when delivered in person or upon confirmation of receipt when transmitted by facsimile transmission (but only if followed by transmittal by national overnight courier for delivery on the next business day), or on receipt after dispatch by registered or certified mail, postage prepaid, addressed, or on the next business day if transmitted by national overnight courier, in each case to the party at their most recent principal business or residence address noted in OmniComm’s books and records for the subject party. The term “business day,” as used herein, shall mean any day on which banks are not required or authorized to close in Florida.

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day and year first above written.

 

	
 
	
 
	
OmniComm Systems, Inc.

	
 
	
 
	
 
	
 

	 	 	 	 
	 	 	By	/s/ Thomas E. Vickers
	 	 	 	 
	 	 	Name:	Thomas E. Vickers
	
 
	
 
	
 
	
 

	 	 	Title:	Chief Financial Officer
	 	 	 	 
	 	 	 	 
	 	 	Pledgor
	 	 	 	 
	 	 	 	 
	 	 	 	 /s/ Cornelis F. Wit
	 	 	Cornelis F. Wit, not individually but as trustee under the provisions of a trust agreement dated April 24, 2012, as amended and known as the Cornelis F. Wit Revocable Trust

 

 

 

 

Signature Page to Pledgor Fee and Reimbursement Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00251-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00251-of-00352.parquet"}]]